Pharmesis International Ratios and Metrics

Market cap in millions SGD. Fiscal year is January - December.

Millions SGD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	11	12	18	3	3	3
Market Cap Growth	39.80%	-33.91%	573.89%	7.89%	-27.33%	-47.37%
Enterprise Value	13	14	21	5	4	4
Last Close Price	0.35	0.38	0.57	0.10	0.11	0.15
PE Ratio	-	-	11.78	-	-	13.89
PS Ratio	1.40	1.50	1.44	0.32	0.26	0.31
PB Ratio	1.10	1.18	1.58	0.27	0.23	0.27
P/TBV Ratio	1.13	1.21	1.62	0.29	0.25	0.29
P/FCF Ratio	221.72	237.34	-	-	2.04	-
P/OCF Ratio	31.10	33.28	-	-	1.97	24.90
EV/Sales Ratio	1.66	1.78	1.67	0.56	0.42	0.40
EV/EBITDA Ratio	-	-	34.91	-	-	8.93
EV/EBIT Ratio	-	-	55.85	-	-	19.59
EV/FCF Ratio	262.96	281.68	-	-	3.34	-
Debt / Equity Ratio	0.28	0.28	0.26	0.31	0.29	0.28
Debt / EBITDA Ratio	-	-	4.12	-	-	5.89
Debt / FCF Ratio	56.87	56.87	-	-	2.61	-
Net Debt / Equity Ratio	0.21	0.21	0.19	0.13	-0.06	0.05
Net Debt / EBITDA Ratio	-9.86	-9.86	3.60	-4.36	2.68	1.36
Net Debt / FCF Ratio	41.24	41.24	-2.75	-0.58	-0.50	-3.40
Asset Turnover	0.41	0.41	0.67	0.50	0.53	0.57
Inventory Turnover	1.83	1.83	2.95	1.88	2.65	3.20
Quick Ratio	0.55	0.55	0.79	0.58	0.82	0.92
Current Ratio	0.96	0.96	1.06	1.09	1.12	1.21
Return on Equity (ROE)	-7.34%	-7.34%	13.14%	-8.82%	-5.42%	3.33%
Return on Assets (ROA)	-1.97%	-1.97%	1.25%	-1.90%	-1.66%	0.72%
Return on Invested Capital (ROIC)	-4.98%	-4.76%	2.71%	-4.86%	-4.32%	1.62%
Return on Capital Employed (ROCE)	-6.00%	-6.00%	3.20%	-5.10%	-4.30%	1.70%
Earnings Yield	-7.03%	-6.57%	8.49%	-34.12%	-27.61%	7.20%
FCF Yield	0.45%	0.42%	-4.35%	-83.72%	49.05%	-5.71%
Buyback Yield / Dilution	-6.13%	-6.13%	-13.08%	-14.85%	-	-

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.